These data suggest that alterations in eNOS and nNOS expression, NADPH oxidase and α-oxoaldehydes may be potential mechanisms by which exercise improves T2DM and obesity. The gene discussed is FMO5; the disease is obesity due to melanocortin 4 receptor deficiency.